Portal de Periódicos da CAPES

Therapy of chronic hepatitis C with α-interferon: The answer? Or more questions?

1991; Lippincott Williams & Wilkins; Volume: 13; Issue: 3 Linguagem: Inglês

10.1002/hep.1840130332

1527-3350

Adrian M. Di Bisceglie, Jay H. Hoofnagle,

Liver Diseases and Immunity

HepatologyVolume 13, Issue 3 p. 601-603 EditorialFree Access Therapy of chronic hepatitis C with α-interferon: The answer? Or more questions? Adrian M. Di Bisceglie M.D., Corresponding Author Adrian M. Di Bisceglie M.D. Liver Diseases Section, Digestive Diseases Branch, National Institutes of Health, Bethesda, Maryland 20892Liver Diseases Section, National Institutes of Health, Bldg. 10, Room 4D52, Bethesda, Maryland 20892===Search for more papers by this authorJay H. Hoofnagle M.D., Jay H. Hoofnagle M.D. Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892Search for more papers by this author Adrian M. Di Bisceglie M.D., Corresponding Author Adrian M. Di Bisceglie M.D. Liver Diseases Section, Digestive Diseases Branch, National Institutes of Health, Bethesda, Maryland 20892Liver Diseases Section, National Institutes of Health, Bldg. 10, Room 4D52, Bethesda, Maryland 20892===Search for more papers by this authorJay H. Hoofnagle M.D., Jay H. Hoofnagle M.D. Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892Search for more papers by this author First published: March 1991 https://doi.org/10.1002/hep.1840130332Citations: 37AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 1–3. 10.1126/science.2523562 Google Scholar 2 Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 3–5. 10.1126/science.2496467 Google Scholar 3 Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–1500. 10.1056/NEJM198911303212202 CASPubMedWeb of Science®Google Scholar 4 Realdi G, Alberti A, Rugge M, Rigoli AM, Tremolada F, Schivazappa L, Ruol A. Long-term follow-up of acute and chronic non-A, non-B hepatitis: evidence of progression to liver cirrhosis. Gut 1982; 23: 270–275. 10.1136/gut.23.4.270 PubMedGoogle Scholar 5 Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakamo Y, Furuta S, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. HEPATOLOGY 1990; 12: 671–675. 10.1002/hep.1840120409 CASPubMedWeb of Science®Google Scholar 6 Marcellin P, Boyer N, Giostra E, Degott C, Courouce M, Degos F, Coppere H, et al. Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. HEPATOLOGY 1991; 13: 393–397. 10.1002/hep.1840130302 CASPubMedWeb of Science®Google Scholar 7 Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986; 315: 1575–1578. 10.1056/NEJM198612183152503 CASPubMedWeb of Science®Google Scholar 8 Thomson BJ, Doran M, Lever AML, Webster ADB. Alpha interferon therapy for non-A, non-B hepatitis transmitted by gamma-globulin replacement therapy. Lancet 1987; 1: 539–541. 10.1016/S0140-6736(87)90178-4 PubMedWeb of Science®Google Scholar 9 Jacyna MR, Brooks MG, Loke RHT, Main J, Murray-Lyon IM, Thomas HC. Randomized controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A, non-B hepatitis. BMJ 1989; 298: 80–82. 10.1136/bmj.298.6666.80 CASPubMedWeb of Science®Google Scholar 10 Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, et al. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized double-blind placebo-controlled trial. N Engl J Med 1989; 321: 1506–1510. 10.1056/NEJM198911303212204 PubMedGoogle Scholar 11 Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989 321: 1501–1506. 10.1056/NEJM198911303212203 PubMedGoogle Scholar 12 Davis GL, Lindsay K, Albrecht J, Bodenheimer HC, Balart LA, Perrillo RP, Dienstag JL, et al. Predictors of response to recombinant alpha interferon (rIFN) treatment in patients with chronic hepatitis C [Abstract]. HEPATOLOGY 1990; 12: 905. Web of Science®Google Scholar 13 Lindsay KL, Davis GL, Bodenheimer HC, Albrecht J, Balart LA, Perrillo RP, Dienstag JL, et al. Predictors of relapse and response to re-treatment in patients with an initial response to recombinant alpha interferon (rIFN) therapy for chronic hepatitis C [Abstract]. HEPATOLOGY 1990; 12: 847. Web of Science®Google Scholar 14 Renault PF, Hoofnagle JH. Side effects of alpha interferon. Semin Liver Dis 1989; 9: 273–277. 10.1055/s-2008-1040523 CASPubMedWeb of Science®Google Scholar 15 Kassianides C, Di Bisceglie AM, Hoofnagle JH, Mullen K, Peters M, Rustgi V, Jones B, et al. Alpha-interferon therapy in patients with decompensated chronic type B hepatitis. In: A Zuckerman, ed. Viral hepatitis and liver disease. New York: Alan R. Liss, 1988: 840–843. Google Scholar 16 Mayet W-J, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Büschenfelde K-H. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. HEPATOLOGY 1989; 10: 24–28. 10.1002/hep.1840100106 PubMedWeb of Science®Google Scholar 17 Deyton LR, Walker RE, Kovacs JA, Herpin B, Parker M, Masur H, Fanci AS. Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med 1989; 321: 1246–1249. 10.1056/NEJM198911023211806 PubMedWeb of Science®Google Scholar 18 Krawczynski K, Kuo G, Di Bisceglie A, Houghton M, Bradley DW. Blood-borne non-A, non-B hepatitis (PT-NANB): Immunohistochemical identification of disease- and hepatitis C virus–associated antigen(s) [Abstract]. HEPATOLOGY 1989; 10: 580. Web of Science®Google Scholar 19 Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990; 335: 1–3. 10.1016/0140-6736(90)90134-Q CASPubMedWeb of Science®Google Scholar 20 Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Baker B, Feinstone SM, Cristiano K, et al. Changes in hepatitis C virus RNA in serum associated with alpha interferon therapy [Abstract]. HEPATOLOGY 1990; 12: 884. Web of Science®Google Scholar 21 Omata M, Yokosuka O, Hosoda K, Kato N, Ohto M. A control study of interferon treatment for acute non-A, non-B hepatitis: effects on hepatitis C virus [Abstract]. HEPATOLOGY 1990; 12: 883. Web of Science®Google Scholar 22 Viladomiu L, Gonzalez A, Lopez-Talavera JC, Genesca J, Allende H, Sanchez C, Hernandez JM, et al. A randomized controlled trial of alpha interferon in acute posttransfusion C hepatitis [Abstract]. J Hepatol 1990; 11: S64. 10.1016/0168-8278(90)91590-S Google Scholar 23 McFarland IG, Smith HM, Johnson PJ, Bray GP, Bergani D, Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet 1990; 335: 754–757. 10.1016/0140-6736(90)90870-B PubMedWeb of Science®Google Scholar Citing Literature Volume13, Issue3March 1991Pages 601-603 ReferencesRelatedInformation